Skip to main content

Lenvatinib tops sorafenib for progression-free survival in HCC

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Lenvatinib tops sorafenib for progression-free survival in HCC

User login

Username

Password

Reset your password

Type	Lead	score